MC1265A1 - Preparation d'un medicament a base de prostaglandines - Google Patents

Preparation d'un medicament a base de prostaglandines

Info

Publication number
MC1265A1
MC1265A1 MC791380A MC1380A MC1265A1 MC 1265 A1 MC1265 A1 MC 1265A1 MC 791380 A MC791380 A MC 791380A MC 1380 A MC1380 A MC 1380A MC 1265 A1 MC1265 A1 MC 1265A1
Authority
MC
Monaco
Prior art keywords
prostacyclin
active compound
amino acid
buffer
solution
Prior art date
Application number
MC791380A
Other languages
English (en)
French (fr)
Inventor
I Watts
P Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1265A1 publication Critical patent/MC1265A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MC791380A 1978-05-17 1979-05-16 Preparation d'un medicament a base de prostaglandines MC1265A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (1)

Publication Number Publication Date
MC1265A1 true MC1265A1 (fr) 1980-03-28

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791380A MC1265A1 (fr) 1978-05-17 1979-05-16 Preparation d'un medicament a base de prostaglandines

Country Status (28)

Country Link
US (1) US4335139A (enExample)
EP (1) EP0005768B1 (enExample)
JP (1) JPS54163809A (enExample)
KR (1) KR830000527B1 (enExample)
AT (2) AT365926B (enExample)
AU (1) AU525695B2 (enExample)
BE (1) BE876296A (enExample)
CA (1) CA1141661A (enExample)
CH (1) CH641044A5 (enExample)
CS (1) CS214798B2 (enExample)
DE (2) DE2920020A1 (enExample)
DK (1) DK156004C (enExample)
ES (1) ES480597A1 (enExample)
FI (1) FI68359C (enExample)
FR (1) FR2425856A1 (enExample)
GR (1) GR68452B (enExample)
HU (1) HU182746B (enExample)
IL (1) IL57298A (enExample)
IT (1) IT1116840B (enExample)
LU (1) LU81272A1 (enExample)
MC (1) MC1265A1 (enExample)
NL (1) NL7903871A (enExample)
NZ (1) NZ190462A (enExample)
PH (1) PH15850A (enExample)
PL (1) PL134004B1 (enExample)
SE (1) SE450930B (enExample)
SU (1) SU978715A3 (enExample)
ZA (1) ZA787353B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
ES2045437T3 (es) * 1988-06-17 1994-01-16 Wellcome Found Analogos de prostaglandinas para empleo en medicina.
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
EP1993557B1 (en) 2006-02-03 2015-11-11 Actelion Pharmaceuticals Ltd. Novel epoprostenol formulation and method of making thereof
EP2711024B1 (en) * 2007-09-07 2019-03-06 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
HU180548B (en) * 1977-05-20 1983-03-28 Wellcome Found Process for preparing pharmaceutical preparations containing a combination of prostacyclin or dihydroprostacyclin with a phosphodiesterase inhibitor

Also Published As

Publication number Publication date
HU182746B (en) 1984-03-28
IT7949064A0 (it) 1979-05-16
GR68452B (enExample) 1981-12-30
JPS54163809A (en) 1979-12-26
LU81272A1 (fr) 1979-12-07
DK201879A (da) 1979-11-18
SE7904284L (sv) 1979-11-18
FR2425856B1 (enExample) 1982-06-25
SU978715A3 (ru) 1982-11-30
FI68359C (fi) 1985-09-10
SE450930B (sv) 1987-08-17
NZ190462A (en) 1982-05-31
CH641044A5 (de) 1984-02-15
AU525695B2 (en) 1982-11-25
PL215627A1 (enExample) 1981-08-07
DK156004C (da) 1989-11-06
CA1141661A (en) 1983-02-22
AU4704279A (en) 1979-11-22
DK156004B (da) 1989-06-12
BE876296A (fr) 1979-11-16
DE2920020A1 (de) 1979-11-29
CS214798B2 (en) 1982-05-28
IL57298A0 (en) 1979-09-30
JPS6358810B2 (enExample) 1988-11-17
IL57298A (en) 1983-09-30
ZA787353B (en) 1980-08-27
EP0005768A1 (en) 1979-12-12
PL134004B1 (en) 1985-07-31
PH15850A (en) 1983-04-13
FI791565A7 (fi) 1979-11-18
FI68359B (fi) 1985-05-31
US4335139A (en) 1982-06-15
ES480597A1 (es) 1980-08-16
EP0005768B1 (en) 1983-08-10
KR830000527B1 (ko) 1983-03-12
ATA363479A (de) 1981-07-15
FR2425856A1 (fr) 1979-12-14
IT1116840B (it) 1986-02-10
DE2920020C2 (enExample) 1988-09-01
AT365926B (de) 1982-02-25
DE2966046D1 (en) 1983-09-15
ATE4411T1 (de) 1983-08-15
NL7903871A (nl) 1979-11-20

Similar Documents

Publication Publication Date Title
FR2678833A1 (fr) Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
KR100401119B1 (ko) 택산계열유도체-기본약학조성물
US9168239B2 (en) Levothyroxine formulations
CH695185A5 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame et procede pour leur production.
MC1265A1 (fr) Preparation d'un medicament a base de prostaglandines
JP4715515B2 (ja) （２ｒ）−２−プロピルオクタン酸を有効成分とする薬剤
KR101468153B1 (ko) 5α-안드로스테인-3β,5,6β-트리올 주사제 및 제조방법
OA12462A (fr) Composition pharmaceutique à base de macrolides pour application locale en ophtalmologie.
JP6165986B2 (ja) ボルテゾミブを含む医薬組成物
CA2351273C (en) Solution of n-[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
CA2416600A1 (en) Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof
BE1007752A5 (fr) Compositions pharmaceutiques de peptides et procedes pour leur preparation.
BE1001704A3 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
FR2715846A1 (fr) Nouvelle composition pharmceutique à base de taxoïdes.
CA2486571C (en) Pharmaceutical composition
JP3956654B2 (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物含有溶液および製剤
JPH0144172B2 (enExample)
CN114728882B (zh) 一种布洛芬酯衍生物及其乳状制剂
JPH07291865A (ja) プロスタグランジンｅ▲１▼の安定化組成物
BE821696A (fr) Procede de preparation d'une formulation stable contenant une prostaglandine du groupe e
EP0449722A1 (fr) Nouveaux complexes de l'acide tiaprofénique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs dérivés

Legal Events

Date Code Title Description
YP Annual fee paid